I.q. Endoscopes Ltd
Manufacture of medical and dental instruments and supplies · Chepstow
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 136 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2025-12-31
IXBRL · 136 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4255_09462661_20251231
- Source archive
- Accounts_Bulk_Data-2026-07-03.zip
Accounts to 2025-12-31
IXBRL · 136 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 136 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 82
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2607_09462661_20251231
- Source archive
- Accounts_Monthly_Data-July2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 136 source facts · 22 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 136 source facts · 22 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 80
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2506_09462661_20241231
- Source archive
- Accounts_Monthly_Data-June2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 127 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 127 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 76
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_09462661_20231231
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2022-12-31
IXBRL · 110 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 110 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 60
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0027_09462661_20221231
- Source archive
- Accounts_Monthly_Data-September2023.zip
Registered details
09462661- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-02-27
- Jurisdiction
- —
- Registered office
- BASEPOINT BUSINESS CENTRE, UNIT 32 RIVERSIDE COURT, CHEPSTOW, WALES, NP16 5UH, WALES
Classification
1 SIC codes32500
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
3 SH01-derived rounds2022-12-21
£5,213,902 raised
£14,685,467 estimated post-money
2022-07-08
£209,999 raised
£10,000,326 estimated post-money
2022-04-13
£290,515 raised
£9,790,327 estimated post-money
Research and innovation
0 matched grantsNo matched UKRI or Innovate UK awards.
Scaleup signal
OECD growth threshold met
37% employee CAGR